GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 223 filers reported holding GENMAB A/S in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,891,056 | -11.7% | 592,318 | -4.8% | 0.70% | -8.6% |
| Q2 2023 | $23,657,690 | +7.1% | 622,407 | +6.4% | 0.77% | +6.2% |
| Q1 2023 | $22,094,849 | -13.8% | 585,139 | -3.3% | 0.72% | -28.1% |
| Q4 2022 | $25,639,137 | -5.5% | 604,982 | -28.4% | 1.00% | -17.8% |
| Q3 2022 | $27,137,000 | -10.5% | 844,609 | -9.5% | 1.22% | -5.1% |
| Q2 2022 | $30,328,000 | -14.6% | 933,449 | -5.0% | 1.29% | +12.8% |
| Q1 2022 | $35,532,000 | -10.9% | 982,087 | -2.6% | 1.14% | +6.1% |
| Q4 2021 | $39,870,000 | -15.5% | 1,007,844 | -6.6% | 1.08% | -15.2% |
| Q3 2021 | $47,164,000 | +8.0% | 1,079,269 | +0.9% | 1.27% | +20.0% |
| Q2 2021 | $43,658,000 | +85.6% | 1,069,256 | +49.2% | 1.06% | +57.8% |
| Q1 2021 | $23,527,000 | -45.4% | 716,646 | -32.4% | 0.67% | -46.4% |
| Q4 2020 | $43,099,000 | +11.8% | 1,059,976 | +0.7% | 1.25% | -13.3% |
| Q3 2020 | $38,536,000 | +66.0% | 1,052,596 | +53.6% | 1.44% | +41.0% |
| Q2 2020 | $23,219,000 | – | 685,116 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $10,291,898 | 3.87% |
| Arlington Capital Management, Inc. | 26,115 | $1,106,754 | 1.24% |
| Dorsey Wright & Associates | 87,451 | $3,706,173 | 1.08% |
| Hardman Johnston Global Advisors LLC | 604,982 | $25,639,137 | 1.00% |
| TORRAY INVESTMENT PARTNERS LLC | 128,564 | $5,448,542 | 0.98% |
| Yorktown Management & Research Co Inc | 16,600 | $703,508 | 0.86% |
| First Light Asset Management, LLC | 160,263 | $6,791,946 | 0.63% |
| KLR INVESTMENT ADVISORS, LLC | 12,604 | $534,158 | 0.44% |
| Campbell & CO Investment Adviser LLC | 42,851 | $1,816,025 | 0.43% |
| Integrated Investment Consultants, LLC | 15,946 | $675,791 | 0.23% |